Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05753020 · ClinicalTrials.gov registry record · NA

A Pilot Study of The CKM JumpStart Tool

A NA study of Chronic Kidney Diseases, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
76
Enrollment target
2
Study locations

NCT05753020 is a NA study of Chronic Kidney Diseases that is actively recruiting participants, run by University of Washington. The registered enrollment target is 76 participants, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05753020, a NA study of Chronic Kidney Diseases, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
76 participants
Enrollment target
2
Study locations

Study Summary

This is a randomized pilot study to test the feasibility and acceptability of a tool to promote discussion about conservative kidney management (CKM) among older patients with advanced CKD and their providers.

Conditions Studied

Interventions

  • BEHAVIORAL CKM Jumpstart Tool

Study Locations (2)

Washington

  • VA Puget Sound Health Care System - Seattle
  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2023-04-10
Est. Completion 2025-12-31
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT05753020

The ClinicalTrials.gov registry entry for NCT05753020 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (83% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which CKM Jumpstart Tool is the first listed.

NCT05753020 reports 2 study locations spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT05753020 about?

NCT05753020 is a clinical study titled "A Pilot Study of The CKM JumpStart Tool". This is a randomized pilot study to test the feasibility and acceptability of a tool to promote discussion about conservative kidney management (CKM) among older patients with advanced CKD and their providers.

What is the current status of trial NCT05753020?

This trial is currently recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2023-04-10. Estimated completion is 2025-12-31.

What conditions does trial NCT05753020 study?

This clinical trial studies the following conditions: Chronic Kidney Diseases.

What interventions are being tested in trial NCT05753020?

The interventions under investigation include: CKM Jumpstart Tool (BEHAVIORAL).

Who is sponsoring clinical trial NCT05753020?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05753020 being conducted?

This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Kidney Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.